IV Dressing Market, By Product Type (Transparent, Translucent), By Application (Reusable, Disposable), By End User (Hospitals, Clinics, Others (Ambulatory Surgical Center etc.)), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023

Code : CMI3182

Pages :153

Formats :

Excel and PDF

Industry : Medical Devices

IV Dressing MarketSize and Trends

The Global IV dressings Market is estimated to be valued at US$ 794.7 million in 2023 and is expected to exhibit a CAGR of 5.3% during the forecast period (2023-2030).

Global IV Dressings Market Segmentation:

The global IV dressings market report is segmented into product type, application, end user and region.

By product type , the market is segmented into transparent and translucent. Out of which, the transparent is expected to hold a dominant position in the global IV dressings market during the forecast period, and this is attributed to increasing product approvals and launches during the forecast period.
By application, the market is segmented into reusable and disposable. Out of which, disposable is expected to dominate the market over the forecast period, and this is attributed to the increasing risk of infectious disease in surgical procedures.
By end user, the market is segmented into hospitals, clinics and others (ambulatory surgical center etc.). Out of which, hospitals, is expected to dominate the market over the forecast period, and this is attributed to the rising number of hospitals and the increasing number of patients admitted per year in hospitals.

Among all the segments, the hospitals segment is expected to dominate the market over the forecast period, and this is attributed to the increasing number of patients admitted per year to hospitals.

Market Trends:

Global IV Dressings Market– Drivers

Rising Incidence of Blood Infections: Increasing incidences of infections such as central line-associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections are expected to boost growth of the I.V. dressing market over the forecast period. For instance, according to a research study published by the National Center for Biotechnology Information in March 2022, Centralline-associated bloodstream infections (CLABSIs) continue to be one of the most common preventable healthcare-associated infections in intensive care units (ICUs) in the U.S. in 2020, with a rate of 0.87 per 1,000 centralline days.
Increasing Number of Surgeries: An increasing number of surgical procedures is anticipated to fuel the global IV dressings market’s growth over the forecast period. For instance, according to an article published by The Journal of the American Medical Association (JAMA) in December 2021, from January 1, 2019 to January 30, 2021, a total of 1,3108,567 surgical procedures were identified based on 3,498 Current Procedural Terminology (CPT) codes. These included 5973573 procedures in 2020 (3,156,240 procedures on women [52.8]). Moreover, 482,637 interventions in children [8.1%] and 1,806,074 procedures in patients aged 65 years [30.2%]).